N6-(4-Methoxyphenyl)pyrido[2,3-d]pyrimidine-2,4,6-triamine

ID: ALA2382315

Chembl Id: CHEMBL2382315

PubChem CID: 71680872

Max Phase: Preclinical

Molecular Formula: C14H14N6O

Molecular Weight: 282.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Nc2cnc3nc(N)nc(N)c3c2)cc1

Standard InChI:  InChI=1S/C14H14N6O/c1-21-10-4-2-8(3-5-10)18-9-6-11-12(15)19-14(16)20-13(11)17-7-9/h2-7,18H,1H3,(H4,15,16,17,19,20)

Standard InChI Key:  OVWODHJGJGNRMS-UHFFFAOYSA-N

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dhfr Dihydrofolate reductase (2343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dihydrofolate reductase (1239 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 282.31Molecular Weight (Monoisotopic): 282.1229AlogP: 1.94#Rotatable Bonds: 3
Polar Surface Area: 111.97Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.02CX LogP: 1.43CX LogD: 1.43
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.67Np Likeness Score: -0.99

References

1. Gangjee A, Namjoshi OA, Raghavan S, Queener SF, Kisliuk RL, Cody V..  (2013)  Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.,  56  (11): [PMID:23627352] [10.1021/jm400086g]
2. Shah K, Queener S, Cody V, Pace J, Gangjee A..  (2019)  Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection.,  29  (15): [PMID:31176699] [10.1016/j.bmcl.2019.06.004]

Source